NON-MELANOMA SKIN CANCER (NMSC)
Clinical trials for NON-MELANOMA SKIN CANCER (NMSC) explained in plain language.
Never miss a new study
Get alerted when new NON-MELANOMA SKIN CANCER (NMSC) trials appear
Sign up with your email to follow new studies for NON-MELANOMA SKIN CANCER (NMSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could existing cancer drugs tackle rare tumors? new trial aims to find out
Disease control Not yet recruitingThis trial tests whether two approved drugs, dabrafenib and trametinib, can treat rare cancers that have a specific genetic change called BRAF V600. These drugs are already used for melanoma and lung cancer, but researchers want to see if they help people with other cancer types.…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New ultrasound technique aims to improve skin cancer surgery outcomes
Knowledge-focused Not yet recruitingThis study looks at whether using a high-frequency ultrasound before surgery for common skin cancers on the head and neck can help surgeons remove the entire tumor the first time. About 400 adults with basal or squamous cell skin cancer will be in the study. Some will get the sta…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Sponsor: Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC